Gregor Hoermann
Overview
Explore the profile of Gregor Hoermann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
154
Citations
2748
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Valent P, Sadovnik I, Peter B, Ivanov D, Schulenburg A, Hadzijusufovic E, et al.
Expert Rev Hematol
. 2023 Jul;
16(9):659-670.
PMID: 37493441
Introduction: The Vienna Cancer Stem Cell Club (VCSCC) was launched by a group of scientists in Vienna in 2002. Areas Covered: Major aims of the VCSCC are to support research...
22.
Loacker L, Egger A, Fux V, Bellmann-Weiler R, Weiss G, Griesmacher A, et al.
Clin Chem Lab Med
. 2023 Jul;
61(12):2248-2255.
PMID: 37401452
Objectives: Immune checkpoints play an important role in maintaining the balance of the immune system and in the development of autoimmune diseases. A central checkpoint molecule is the programmed cell...
23.
Huber S, Baer C, Hutter S, Dicker F, Meggendorfer M, Pohlkamp C, et al.
Leukemia
. 2023 Apr;
37(7):1413-1420.
PMID: 37120689
In parallel to the 5th edition of the World Health Organization Classification of Haematolymphoid Tumours (WHO 2022), an alternative International Consensus Classification (ICC) has been proposed. To evaluate the impact...
24.
Willmann M, Peter B, Slavnitsch K, Berger D, Witzeneder N, Stefanzl G, et al.
Leukemia
. 2023 Mar;
37(5):1162-1165.
PMID: 36918646
No abstract available.
25.
Degenfeld-Schonburg L, Gamperl S, Stefanzl G, Schruef A, Sadovnik I, Bauer K, et al.
Am J Cancer Res
. 2023 Mar;
13(2):355-378.
PMID: 36895976
Systemic mastocytosis (SM) is a hematopoietic neoplasm with a complex pathology and a variable clinical course. Clinical symptoms result from organ infiltration by mast cells (MC) and the effects of...
26.
Valent P, Hartmann K, Bonadonna P, Sperr W, Niedoszytko M, Hermine O, et al.
J Allergy Clin Immunol Pract
. 2023 Mar;
11(6):1706-1717.
PMID: 36868470
In 2002, the European Competence Network on Mastocytosis (ECNM) was launched as a multidisciplinary collaborative initiative to increase the awareness and to improve diagnosis and management of patients with mast...
27.
Ivanov D, Milosevic Feenstra J, Sadovnik I, Herrmann H, Peter B, Willmann M, et al.
Am J Hematol
. 2023 Feb;
98(5):770-783.
PMID: 36814396
Myeloproliferative neoplasms (MPN) are characterized by uncontrolled expansion of myeloid cells, disease-related mutations in certain driver-genes including JAK2, CALR, and MPL, and a substantial risk to progress to secondary acute...
28.
Huber S, Haferlach T, Muller H, Meggendorfer M, Hutter S, Hoermann G, et al.
Leukemia
. 2023 Feb;
37(4):942-945.
PMID: 36813994
No abstract available.
29.
Mayerhofer E, Strecker C, Becker H, Georgakis M, Uddin M, Hoffmann M, et al.
Stroke
. 2023 Feb;
54(4):938-946.
PMID: 36789775
Background: Undetermined stroke etiology hampers optimal secondary prevention in a large proportion of young patients. We explored whether genetic screening for clonal hematopoiesis of indetermined potential (CHIP), a novel risk...
30.
Sonnweber T, Grubwieser P, Pizzini A, Boehm A, Sahanic S, Luger A, et al.
Sci Rep
. 2023 Feb;
13(1):2599.
PMID: 36788324
The severity of coronavirus disease 2019 (COVID-19) is related to the presence of comorbidities including metabolic diseases. We herein present data from the longitudinal prospective CovILD trial, and investigate the...